[go: up one dir, main page]

WO1997031114A3 - Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus - Google Patents

Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus Download PDF

Info

Publication number
WO1997031114A3
WO1997031114A3 PCT/GB1997/000524 GB9700524W WO9731114A3 WO 1997031114 A3 WO1997031114 A3 WO 1997031114A3 GB 9700524 W GB9700524 W GB 9700524W WO 9731114 A3 WO9731114 A3 WO 9731114A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
staphylococcus aureus
aminoacid sequences
polypeptides
relates
Prior art date
Application number
PCT/GB1997/000524
Other languages
English (en)
Other versions
WO1997031114A2 (fr
Inventor
Martin Karl Russell Burnham
John Edward Hodgson
Original Assignee
Smithkline Beecham Plc
Martin Karl Russell Burnham
John Edward Hodgson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Martin Karl Russell Burnham, John Edward Hodgson filed Critical Smithkline Beecham Plc
Priority to EP97905269A priority Critical patent/EP0822987A2/fr
Priority to JP9529922A priority patent/JPH11506022A/ja
Publication of WO1997031114A2 publication Critical patent/WO1997031114A2/fr
Publication of WO1997031114A3 publication Critical patent/WO1997031114A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des polynucléotides staphylococciques, des polypeptides codés par des polynucléotides de ce type, l'utilisation de ces polynucléotides et de ces polypeptides. L'invention a aussi pour objet la production de ces polynucléotides et de ces polypeptides et de cellules hôtes de recombinaison transformées par les polynucléotides. L'invention traite également de l'inhibition de la biosynthèse ou de l'action de ces polynucléotides ou polypeptides et de l'utilisation de ces inhibiteurs dans des applications thérapeutiques.
PCT/GB1997/000524 1996-02-26 1997-02-25 Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus WO1997031114A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97905269A EP0822987A2 (fr) 1996-02-26 1997-02-25 Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus
JP9529922A JPH11506022A (ja) 1996-02-26 1997-02-25 スタフィロコッカス・アウレウス由来のポリヌクレオチドおよびアミノ酸配列

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9604045.6 1996-02-26
GBGB9604045.6A GB9604045D0 (en) 1996-02-26 1996-02-26 Novel compounds

Publications (2)

Publication Number Publication Date
WO1997031114A2 WO1997031114A2 (fr) 1997-08-28
WO1997031114A3 true WO1997031114A3 (fr) 1997-10-23

Family

ID=10789423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000524 WO1997031114A2 (fr) 1996-02-26 1997-02-25 Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus

Country Status (4)

Country Link
EP (1) EP0822987A2 (fr)
JP (1) JPH11506022A (fr)
GB (1) GB9604045D0 (fr)
WO (1) WO1997031114A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
US6204019B1 (en) 1997-06-04 2001-03-20 Smithkline Beecham Corporation Sec A2 from Streptococcus pneumoniae
EP0961778A1 (fr) * 1997-10-03 1999-12-08 Smithkline Beecham Corporation 3-hydroxyacyl-coa deshydrogenase due au staphylococcus aureus
EP0913474A3 (fr) * 1997-10-28 1999-12-29 Smithkline Beecham Corporation Dbpa, une hélicase de Staphylococcus aureus
CA2337966A1 (fr) * 1998-07-10 2000-01-20 U.S. Medical Research Institute Of Infectious Diseases Vaccin contre l'intoxication par les staphylocoques
AU2002249514B8 (en) * 2002-03-26 2008-10-09 Council Of Scientific And Industrial Research Primers for detecting food poisoning bacteria and a use thereof
JP2004313181A (ja) * 2003-04-02 2004-11-11 Canon Inc 感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
US12163135B2 (en) 2017-12-05 2024-12-10 BioPlx, Inc. Methods and compositions to prevent microbial infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000493A1 (fr) * 1992-06-29 1994-01-06 Archana Kapoor Immunogenes associes a la membrane de mycobacteries
WO1994022895A1 (fr) * 1993-04-05 1994-10-13 National Jewish Center For Immunology And Respiratory Medicine Molecule d'acide nucleique isolee codant pour des toxines associees au syndrome de kawasaki et utilisations de cette molecule

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000493A1 (fr) * 1992-06-29 1994-01-06 Archana Kapoor Immunogenes associes a la membrane de mycobacteries
WO1994022895A1 (fr) * 1993-04-05 1994-10-13 National Jewish Center For Immunology And Respiratory Medicine Molecule d'acide nucleique isolee codant pour des toxines associees au syndrome de kawasaki et utilisations de cette molecule

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BETLEY AND MEKALANOS: "Nucleotide sequence of the type A staphylococcal enterotoxin gene", JOURNAL OF BACTERIOLOGY, vol. 170, no. 1, January 1988 (1988-01-01), pages 34 - 41, XP000676708 *
Database EMBL, Entry ODBETTUB, ion number L10111, 4.Febr 994; nt.1970-1991 00% homologous with Seq.ID:1 nt.2 *
Database EMBL, Entry SMPMI, ion number D16594, 17.Jun ; nt.519-533 a -591 are 100% homologouswith Seq.ID:1 nt.4 *
YOUNG ET AL.: "Dissection of Mycobacterium tuberculosis antigens using recombinant DNA", PROC. NATL. ACAD. SCI. USA, vol. 82, May 1985 (1985-05-01), pages 2583 - 2587, XP002034045 *

Also Published As

Publication number Publication date
WO1997031114A2 (fr) 1997-08-28
JPH11506022A (ja) 1999-06-02
GB9604045D0 (en) 1996-04-24
EP0822987A2 (fr) 1998-02-11

Similar Documents

Publication Publication Date Title
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
AU2003303458A1 (en) Ampholytic copolymer and use thereof
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
AU1097700A (en) Protection of boot block code while allowing write accesses to the boot block
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
AU5155996A (en) Control of pod dehiscence
WO1997031114A3 (fr) Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
AU5305000A (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2002002630A3 (fr) Nouvelles utilisations
WO2003035878A3 (fr) Variantes de lipase
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
WO2007069249A3 (fr) Polypeptides de type toxine, polynucleotides codant pour ceux-ci et utilisations de ceux-ci
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres
WO1999002724A3 (fr) Procede d'identification de genes exprimes dans des lignees selectionnees et nouveaux genes identifies au moyen de ces procedes
WO2003015825A3 (fr) Conjugue
WO2003044047A3 (fr) Genes de virulence, proteines, et leurs utilisations
AU5619700A (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2002055685A3 (fr) Nouvelle kinase humaine et polynucleotides codant pour cette kinase
WO1996003435A3 (fr) Gamma-interferon d'origine feline
AU2003234717A1 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
EP1576099A3 (fr) Nouveaux polynucleotides codant le polypeptide kinase citron humain, bmsnkc 0020/0021
WO2000075321A3 (fr) Nouveaux polynucleotides et polypeptides codant pour lesdits polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1997905269

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 529922

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997905269

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997905269

Country of ref document: EP